Asian stocks, euro gain after Trump delays EU tariffs
SINGAPORE, May 26 (Reuters) - Stock markets across Asia edged higher on Monday, and the euro rallied after President Donald Trump abruptly extended by more than a month his threat to slap 50% tariffs on EU goods, marking another temporary reprieve as part of his erratic trade policy.
On Sunday, Trump agreed to extend his deadline for trade talks until July 9, from the June 1 deadline he set on Friday, after European Commission President Ursula von der Leyen said the bloc needed more time to "reach a good deal."
Market sentiment had been steadying after a sharp selloff across most assets last month as Trump paused his growth-denting tariffs and investors were keen on fresh trade deals after a pact with UK and a temporary agreement with China.
However, Trump's latest policy moves were a reminder to investors how quickly circumstances could change and analysts have been pointing out that investors are shifting their money out of the U.S. to Europe and Asia as they price in a possible U.S. recession and a consequent global slowdown.
"(The tariffs are) well above the 20% original reciprocal tariff on the EU. The U.S., EU, and China account for 60% of global GDP and so this escalation bodes ill for the entire world," analysts at Brown Brothers Harriman said in a note.
Apple (AAPL.O), opens new tab was also caught in the trade crossfire on Friday, after Trump threatened a 25% levy on all imported iPhones bought by U.S. consumers.
On Monday, MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS), opens new tab inched up 0.12%, while Japan's Nikkei (.N225), opens new tab was marginally higher.
Trading volumes on Monday are expected to be thin given that markets in the United States and the United Kingdom are closed due to public holidays.
Japan's Nippon Steel's (5401.T), opens new tab jumped 4.3% after Trump on Friday expressed support for the company's $14.9 billion bid for U.S. Steel (X.N), opens new tab, saying their "planned partnership" would create jobs and help the American economy. Shares of U.S. Steel soared 21% on Friday.
Super-long Japanese bonds will be in focus, with inflation data expected later in the week as investors try to gauge the Bank of Japan's monetary policy outlook. Yields on the tenors hit record levels last week.
Ballooning debt levels in developed economies were also brought back into focus following Moody's credit rating downgrade of the United States and weak debt auctions in the U.S. and Japan last week.
China's blue-chip index (.CSI300), opens new tab slipped 0.2% in early trading on Monday, while Hong Kong's Hang Seng Index (.HSI), opens new tab dipped 0.4%.
Among currencies, the euro strengthened 0.3% to $1.1397 to touch its highest since April 30, while the greenback recovered as much as 0.3% to 143.085 yen , after diving 1% on Friday.
On Wednesday, an earnings report from artificial intelligence bellwether Nvidia (NVDA.O), opens new tab will be in the spotlight - the last of the "Magnificent Seven" group of growth stocks that had spearheaded a more than two-year U.S. bull market.
Analysts said the semiconductor giant's quarterly report could be the next catalyst for markets, given its forecasts are seen as an indication of demand for tech infrastructure.
Nvidia's shares are down more than 2% this year after investors took notice of cheaper Chinese AI models in the aftermath of DeepSeek's release, while CEO Jensen Huang has flagged that U.S. export curbs will also hit sales.
Reuters reported on Saturday that Nvidia will launch a new AI chipset for China at a significantly lower price, subject to U.S. government approval.
On the commodities front, crude prices traded higher, while gold eased marginally from a two-week high.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
3 hours ago
- The Guardian
Newsom is warned of ‘criminal tax evasion' if he withholds federal taxes
The US treasury secretary, Scott Bessent, has warned California governor Gavin Newsom that he would be guilty of 'criminal tax evasion' if he withholds his state's tax payments to the federal government amid threats of a funding cut by Donald Trump. Newsom had threatened to cut tax payments to the federal government two days ago after reports that Trump was preparing huge federal funding cuts targeting Democrat-dominated California, including its state university system. 'Gavin Newsom is threatening to commit criminal tax evasion,' Bessent said in a post on X. 'His plan: defraud the American taxpayer and leave California residents on the hook for unpaid federal taxes.' Bessent continued: 'I am certain most California businesses know that failing to pay taxes owed to the Treasury constitutes tax evasion and have no intention of following the dangerous path Governor Gavin Newsom is threatening.' He described Newsom's comments as 'extremely reckless' and advised the governor to come up with a tax-cutting plan for California that mirrored Trump's federal tax cutting plan, 'instead of committing criminal tax evasion'. The treasury secretary's comments came after Newsom posted on Friday that 'Californians pay the bills for the federal government. We pay over $80 BILLION more in taxes than we get back. Maybe it's time to cut that off, Donald Trump.' The California governor linked to a CNN report that the Trump administration is preparing to cancel some federal funding for California and federal agencies had been directed to identify grants that could be withheld, including the University of California and California state university systems. In a statement on Friday, the White House spokesperson Kush Desai criticized California's energy, immigration and other positions as 'lunatic anti-energy, soft-on-crime, pro-child mutilation, and pro-sanctuary policies'. 'No taxpayer should be forced to fund the demise of our country,' Desai said, but he added that 'No final decisions, however, on any potential future action by the Administration have been made, and any discussion suggesting otherwise should be considered pure speculation.' Newsom and Trump are accustomed to a war of words, including threats to withhold funding. The administration recently cut $126m in flood prevention funding projects, and Trump has threatened 'large-scale fines' on the state after transgender athlete AB Hernandez competed in the long jump, high jump and triple jump events at the California Interscholastic Federation track and field championships. But the reported threat to cut off federal funding to California's university system appears to have pushed California officials into threats of retaliation. Soon before Newsom made his threat, California assembly speaker Robert Rivas described the rumored grant cancellations as 'unconstitutional and vindictive.' 'We're the nation's economic engine and the largest donor state, and deserve our fair share,' Rivas wrote. 'I'll use every legal and constitutional tool available to defend CA – we must look at every option, including withholding federal taxes.'
Auto Blog
3 hours ago
- Auto Blog
Japan's Sub-$10K EV Seats One But Turns Heads
Tiny cars have never not been cool, but the one-seater MiBot from Japan-based KG Motors is making a real impression on the car-buying public A small 'mobility robot' could change the way Japan gets around Pricing is one of many reasons EV market penetration worldwide is slow. But in Japan, a country historically not as dependent on the automobile as places like the United States, the electric vehicle segment is growing at a particularly modest pace. With just 3.5 percent of the market share in Japan as of 2023, compared to a global percentage nearer to 20 percent, EVs are far from the popular choice. But a company called KG Motors, based near Hiroshima, is hoping that will change with their idea of the perfect city car: the MiBot. The MiBot is small and perfect for getting downtown KG Motors MiBot — Source: KG Motors Really, there's only one way to say it: the KG Motors MiBot is tiny. The single seater measures 98 inches long, 44 inches wide, and stands just 57 inches tall, making it more or less the size of a golf cart. Under the admittedly adorable exterior beats an electric heart that offers up to 62 miles of range at up to 37 mph. A 7.68 kWh LFP battery pack charges in around five hours on a 100-volt outlet, which is Japan's standard. Despite a spartan interior — KG Motors proudly touts 'doors and air conditioners are standard' — the company says it's looking into 'autonomous driving functions.' Reservations opened up last August, and KG Motors has already secured over 2,000 pre-orders. Now, small cars and electrification aren't a new pairing in Japan. The Nissan Sakura, arguably the most popular EV in Japan, is in fact a kei car. But the KG Motors MiBot differs in a few key ways. Funny enough, the most important difference is that it's smaller, conforming to regulations in Japan defining a 'microcar.' That's distinct from even the small kei car. Microcars benefit from lower insurance rates, no required inspections, and freedom from some other local regulations. The second most important part is pricing. Priced at roughly the equivalent of $7,650, the MiBot is less than half the price of the Sakura. KG Motors MiBot — Source: KG Motors MiBot, like Slate Auto, is filling a gap that legacy automakers seem to be content to ignore We won't be so bold as to suggest the MiBot would be a pragmatic choice, or at all successful, Stateside. We also recognize that there isn't anything quite analogous to a microcar that exists in the US. However, with KG Motors seeing a positive response in a country that otherwise eschews electrification in favor of gas — or nothing at all — it seems that pricing is perhaps a bigger factor than legacy automakers realize. Slate Auto is seeing a hugely successful reservation period, and the two share a common approach: few frills, and a price that undercuts everyone else, especially legacy automakers. Autoblog Newsletter Autoblog brings you car news; expert reviews and exciting pictures and video. Research and compare vehicles, too. Sign up or sign in with Google Facebook Microsoft Apple By signing up I agree to the Terms of Use and acknowledge that I have read the Privacy Policy . You may unsubscribe from email communication at anytime. KG Motors MiBot — Source: KG Motors Final thoughts In an interview with Bloomberg, KG Motors said the 'first batch' of MiBots will allow the company to 'break even,' financially speaking. Following reservation fulfillments, the MiBot makers will start churning these little guys out at a rate of 10,000 units per year. It's important to remember that Toyota, the world's largest automaker, sold around 2,000 EVs total in Japan last year. Price isn't everything, but we have a feeling keeping it low is a big boost for little cars like the MiBot in Japan, and value-packed offerings from companies like Slate in the US. About the Author Steven Paul View Profile
Reuters
4 hours ago
- Reuters
Otsuka's kidney disease therapy trial results heat up battle with rival Vera
June 6 (Reuters) - Otsuka's (4578.T), opens new tab experimental therapy for a potentially life-threatening kidney disease more than halved severe levels of protein in the urine of patients, intensifying the battle for an effective new treatment with rival Vera Therapeutics (VERA.O), opens new tab. The Japan-based company said on Friday its therapy, sibeprenlimab, cut proteinuria levels by 51.2% in patients with Immunoglobulin A Nephropathy, also known as Berger's disease, at nine months in a late-stage trial. The data comes just days after Vera said its drug, atacicept, reduced protein levels in patients' urine by 46%, compared with a 7% reduction with a placebo, meeting the main goal of a 428-patient late-stage study. Shares of the U.S.-based drug developer slid 31% to $20.89. Analysts, however, said that though data from Otsuka's sibeprenlimab might look superior, it was unlikely that doctors would interpret it that way. The difference between the two datasets is not too clinically diverse to affect demand for Vera's drug, said Jefferies analyst Farzin Haque. Berger's disease causes abnormal protein buildup in the kidneys and could eventually lead to the organ's failure. Analysts have estimated the U.S. market for its treatments could be worth as much as $10 billion. Otsuka has already applied for the FDA's accelerated approval for its therapy to treat the disease. However, its sales would largely depend on whether the treatment can improve kidney function, analysts said. Even if the drug gains accelerated approval, Otsuka said it plans to study whether it can preserve the organ's ability to filter toxins from blood, measured as the glomerular filtration rate (eGFR). "The magnitude of the protein reduction should translate into eGFR preservation down the line, because ultimately that's what patients are going to be asking for," Dana Rizk, the trial's investigator and a professor of medicine at the University of Alabama in Birmingham, told Reuters. The study is expected to be completed in early 2026.
